Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase NA 21Phase 1/2 10Phase 1 10Phase 3 8Phase EARLY_PHASE1 3Phase 4 3Phase 2/3 3

Status

Completed 14Unknown 4Terminated 4Recruiting 3Not yet recruiting 3Withdrawn 2Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Thoracic 1

Conditions

Breast Neoplasms 20Carcinoma, Hepatocellular 8Stomach Neoplasms 6Multiple Myeloma 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 4Endometrial Neoplasms 4Small Cell Lung Carcinoma 3Recurrence 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Melanoma 3Febrile Neutropenia 3Waldenstrom Macroglobulinemia 2Venous Thromboembolism 2Skin Neoplasms 2Pancreatic Neoplasms 2Pancreatic Cancer Non-resectable 2Obesity 2Neoplasm Metastasis 2Lymphoma, B-Cell 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hepatitis B 2Hematologic Neoplasms 2Gastric / Gastroesophageal Junction Adenocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Anemia 2

Interventions

niraparib 1Pafolacianine 1Injections 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Not yet recruiting × Ovarian Neoplasms × Clear all
NCT07469202 2026-03-13

CYTALUX Dose Extension Study

On Target Laboratories, LLC

Phase 4 Not yet recruiting
106 enrolled
GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms

NCT06887933 2025-03-21

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

GlaxoSmithKline

Phase 4 Not yet recruiting
67 enrolled
Gynecologic

Ovarian Neoplasms

NCT06871787 2025-03-14

INOCA

Istanbul University

Phase 4 Not yet recruiting
50 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡